Previous close | 60.55 |
Open | 60.76 |
Bid | 63.64 x 200 |
Ask | 63.75 x 200 |
Day's range | 60.21 - 64.24 |
52-week range | 44.20 - 82.04 |
Volume | |
Avg. volume | 745,949 |
Market cap | 6.929B |
Beta (5Y monthly) | 0.89 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Full Year Earnings Reveal Strong Revenue Growth but Operational Challenges Persist
Andrew Guggenhime, President and Chief Financial Officer of Vaxcyte Inc (NASDAQ:PCVX), has sold 8,000 shares of the company on March 18, 2024, according to a recent SEC filing.
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]